Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 190

1.

Disturbances in gamma globulin synthesis as experiments of nature.

GOOD RA, ZAK SJ.

Pediatrics. 1956 Jul;18(1):109-49. No abstract available.

PMID:
13335330
2.

Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine.

Leifert JA, Lindencrona JA, Charo J, Whitton JL.

Hum Gene Ther. 2001 Oct 10;12(15):1881-92.

PMID:
11589830
3.
4.

Targeting dendritic cells to enhance DNA vaccine potency.

You Z, Huang X, Hester J, Toh HC, Chen SY.

Cancer Res. 2001 May 1;61(9):3704-11.

5.

Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.

Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M, Wu TC.

Cancer Res. 2001 May 1;61(9):3698-703.

7.

Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.

Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC.

Gene Ther. 2001 Jan;8(2):128-38.

8.

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M, Wu TC.

J Immunol. 2001 May 1;166(9):5733-40.

9.

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine.

Velders MP, Weijzen S, Eiben GL, Elmishad AG, Kloetzel PM, Higgins T, Ciccarelli RB, Evans M, Man S, Smith L, Kast WM.

J Immunol. 2001 May 1;166(9):5366-73.

10.

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Tanghe A, D'Souza S, Rosseels V, Denis O, Ottenhoff TH, Dalemans W, Wheeler C, Huygen K.

Infect Immun. 2001 May;69(5):3041-7.

11.

Preferential localization of effector memory cells in nonlymphoid tissue.

Masopust D, Vezys V, Marzo AL, Lefrançois L.

Science. 2001 Mar 23;291(5512):2413-7. Epub 2001 Mar 1.

12.

Relative potency of cellular and humoral immune responses induced by DNA vaccination.

Otten GR, Doe B, Schaefer M, Chen M, Selby MJ, Goldbeck C, Hong M, Xu F, Ulmer JB.

Intervirology. 2000;43(4-6):227-32.

PMID:
11251378
13.

Multivalent minigene vaccines against infectious disease.

An LL, Whitton JL.

Curr Opin Mol Ther. 1999 Feb;1(1):16-21. Review. No abstract available.

PMID:
11249678
14.

Advances in plasmid gene delivery and expression in skeletal muscle.

Smith LC, Nordstrom JL.

Curr Opin Mol Ther. 2000 Apr;2(2):150-4. Review.

PMID:
11249635
15.

Intralymphatic immunization enhances DNA vaccination.

Maloy KJ, Erdmann I, Basch V, Sierro S, Kramps TA, Zinkernagel RM, Oehen S, Kündig TM.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3299-303. Epub 2001 Feb 27.

16.
17.
18.
19.

The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.

Chan K, Lee DJ, Schubert A, Tang CM, Crain B, Schoenberger SP, Corr M.

J Immunol. 2001 Mar 1;166(5):3061-6.

20.

Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse.

Bachy M, Boudet F, Bureau M, Girerd-Chambaz Y, Wils P, Scherman D, Meric C.

Vaccine. 2001 Feb 8;19(13-14):1688-93.

PMID:
11166892

Supplemental Content

Support Center